Global Next Generation Cancer Diagnostics Market Size & Outlook

The next generation cancer diagnostics industry worldwide is expected to reach a projected revenue of US$ 29,305.1 million by 2030. A compound annual growth rate of 9.3% is expected of the worldwide next generation cancer diagnostics industry from 2024 to 2030.

Revenue, 2023 (US$M)
$15,729.4
Forecast, 2030 (US$M)
$29,305.1
CAGR, 2024 - 2030
9.3%
Report Coverage
Worldwide

Global next generation cancer diagnostics market highlights

  • The global next generation cancer diagnostics market generated a revenue of USD 15,729.4 million in 2023 and is expected to reach USD 29,305.1 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 9.3% by 2030.
  • In terms of segment, next generation sequencing accounted for a revenue of USD 5,806.6 million in 2023.
  • Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 15,729.4 million
Market revenue in 2030USD 29,305.1 million
Growth rate9.3% (CAGR from 2023 to 2030)
Largest segmentNext generation sequencing
Fastest growing segmentNext Generation Sequencing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNext Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays

Other key industry trends

  • In terms of revenue, the North America accounted for 40.4% of the global next generation cancer diagnostics market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 8,207.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Next Generation Cancer Diagnostics Market Scope

Next generation cancer diagnostics market segmentation & scope
Next Generation Sequencing
qPCR & Multiplexing
LOAC & RT-PCR
Protein Microarrays
DNA Microarrays
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Theapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis

Next Generation Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Global next generation cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.


next generation sequencing was the largest segment with a revenue share of 36.92% in 2023. Horizon Databook has segmented the Global next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Next Generation Cancer Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
    • Next Generation Sequencing
    • qPCR & Multiplexing
    • LOAC & RT-PCR
    • Protein Microarrays
    • DNA Microarrays
  • Global Next Generation Cancer Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
    • Biomarker Development
    • CTC Analysis
    • Proteomic Analysis
    • Epigenetic Analysis
    • Genetic Analysis
  • Global Next Generation Cancer Diagnostics Cancer Type Outlook (Revenue, USD Million, 2018-2030)
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Others
  • Global Next Generation Cancer Diagnostics Function Outlook (Revenue, USD Million, 2018-2030)
    • Theapeutic Monitoring
    • Companion Diagnostics
    • Prognostics
    • Cancer Screening
    • Risk Analysis

Reasons to subscribe to Global next generation cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global next generation cancer diagnostics market databook

  • Our clientele includes a mix of next generation cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global next generation cancer diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global next generation cancer diagnostics market statistics, by region, 2018-2030 (US$M)

Top 10 countries: Next generation cancer diagnostics market size, 2023 (USD Million)

Top 10 countries: Next generation cancer diagnostics market size, 2023 (USD Million)

Global next generation cancer diagnostics market, by region, 2023 (US$M)

Global next generation cancer diagnostics market statistics, by region, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more